Keywords: bioalliance, gets, afssaps, ok, ph, ii/iii, liver

BioAlliance gets AFSSAPS ok for Ph II/III liver cancer trial

Article | 18 December 2006

Print This

France's BioAlliance Pharma SA, a specialty drugmaker, says that the country's medical agency, the AFSSAPS, has given the go ahead ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in